Phase 2 Obesity Trial, Recruiting NCT06755827 Sponsor: Texas Tech University Condition: Obesity
Back to Obesity

Phase 2 Obesity Trial, Recruiting

NCT06755827
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are proficient in English
  • Young people between the ages of 11 and 14
  • Young people whose BMI is at or above the 85th percentile for their age and sex (a measure used to assess body weight relative to other children of the same age and sex)
  • People who have access to WiFi or cellular data, as some sessions are held online via telehealth
  • People who live in Lubbock County, Texas, or the surrounding areas

Who may not be able to join:

  • People who have a psychiatric or medical condition that would interfere with taking part in the study (for example, significant developmental delays or pregnancy)
  • People who are currently enrolled in another weight management or obesity treatment program
  • People who are unable to safely enter an MRI scanner — for example, those who have implanted medical devices with batteries, piercings on the head or face, or significant vision problems that cannot be corrected with glasses provided by the study staff (confirm with trial site for the full list of MRI-related criteria)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 806-834-0931

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Texas Tech University
Registry
ClinicalTrials.gov
Start date
24 March 2026
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percentage BOLD (Blood Oxygenation Level Dependent) signal change; Glucose tolerance per blood samples; Triglycerides per blood samples; Cholesterol per blood samples; C peptide per blood samples; Emotion regulation per Difficulties in Emotion Regulation Scale-Short Form (DERS-SF) and Positive Affect (DERS-PA) versions; Self-report disordered eating cognitions and behaviors per Eating Disorder Examination-Questionnaire; Self-report average daily minutes and intensity of physical activity per Patient-Reported Outcomes Measurement Information System (PROMIS) scale; Self-report average daily minu...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov